Piper Jaffray analyst Michael Olson is maintaining his long-term bullish stance on Amazon.com, Inc.
Alphabet Inc (NASDAQ:GOOGL) released a fourth-quarter print yesterday after market close that has analysts from Aegis and Jefferies cheering for the tech giant …
Canaccord’s top analyst Matt Ramsay weighed in today on chip giant Advanced Micro Devices, Inc. (NASDAQ:AMD), summarizing expectations and key topics ahead of earnings on Tuesday, January 31.
Yesterday morning, Ironwood (NASDAQ:IRWD) and Allergan (NYSE:AGN) announced that the FDA approved a lower dose (72mcg) of Linzess (linaclotide). The dosage levels approved for …
Roth Capital’s top analyst Brian Alger is out this morning with a new research note on Super Micro Computer, Inc. (NASDAQ:SMCI), after the high-end server maker posted …
Oppenheimer analysts are chiming in with upbeat forecasts on two biotech players: Celgene Corporation (NASDAQ:CELG) and Synergy Pharmaceuticals Inc (NASDAQ:SGYP). One analyst is out …
BTIG analyst Tim Chiang remains positive on shares of Synergy Pharmaceuticals Inc (NASDAQ:SGYP) following news of Allergan (NYSE:AGN) and Ironwood (NASDAQ:IRWD) receiving approval of their …
Allergan (NYSE:AGN) and Ironwood Pharmaceuticals (NASDAQ:IRWD) announced this morning the approval of the 72 mcg formulation of Linzess for the treatment of chronic …
Synergy Pharmaceuticals Inc’s (NASDAQ:SGYP) constipation drug Trulance will compete directly with Ironwood Pharmaceuticals (NASDAQ:IRWD) and Allergan‘s (NYSE:AGN) drug Linzess, which received FDA approval this …
Avinger Inc (NASDAQ:AVGR) shares jumped over 30% in pre-market trading Thursday, after the company presented positive two-year clinical data from the pivotal VISION study, …
